Skip to main content
logo
SpyGlass Pharma, Inc. (SGP)
NASDAQ: SGP · Real-Time Price · USD
21.62
+0.80 (3.84%)
Jul 28, 2026, 4:00 PM EDT - Market closed

SpyGlass Pharma Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
FY 2025FY 2024FY 2023
Period Ending
Dec '25 Dec '24 Dec '23
Net Income
-39.87-29.16-13.32
Depreciation & Amortization
0.610.270.12
Stock-Based Compensation
2.791.490.87
Other Adjustments
1.43.820.12
Change in Receivables
-0.01-0.3-0.09
Changes in Accounts Payable
0.551.340.17
Changes in Accrued Expenses
2.571.010.27
Changes in Other Operating Activities
-0.74-0.49-0.43
Operating Cash Flow
-32.7-22.03-12.28
Operating Cash Flow Growth
---

Investing Activities

Fiscal Year
FY 2025FY 2024FY 2023
Period Ending
Dec '25 Dec '24 Dec '23
Capital Expenditures
-0.79-1.99-0.22
Purchases of Investments
-17-20.63-34.04
Proceeds from Sale of Investments
644.8813.77
Investing Cash Flow
-11.7922.26-20.49

Financing Activities

Fiscal Year
FY 2025FY 2024FY 2023
Period Ending
Dec '25 Dec '24 Dec '23
Issuance of Common Stock
0.170.190.01
Repurchase of Common Stock
-1.45--
Net Common Stock Issued (Repurchased)
-1.280.190.01
Issuance of Preferred Stock
127.34-40.01
Net Preferred Stock Issued (Repurchased)
127.34-40.01
Other Financing Activities
-1.47--0.25
Financing Cash Flow
124.590.1939.77

Net Cash Flow

Fiscal Year
FY 2025FY 2024FY 2023
Period Ending
Dec '25 Dec '24 Dec '23
Net Cash Flow
80.090.427.01

Free Cash Flow

Fiscal Year
FY 2025FY 2024FY 2023
Period Ending
Dec '25 Dec '24 Dec '23
Free Cash Flow
-33.49-24.02-12.49
Free Cash Flow Growth
---
Free Cash Flow Per Share
-15.11-13.43-7.19
Levered Free Cash Flow
-37.66-29.03-13.4
Unlevered Free Cash Flow
-39.24-26.93-14.31
SEC Filings: 10-K · 10-Q